The DRD2 inverse agonist and antipsychotic haloperidol improved the efficacy of an epidermal growth factor receptor inhibitor, although haloperidol (which also has efficacy in the nanomolar range on DRD3, DRD4, and several other receptors) was insufficient to decrease tumor growth alone [22]. This evidence concerns the gene DRD2 and neoplasm.